NEW YORK (GenomeWeb) – The US Food and Drug Administration today announced it has granted Emergency Use Authorization to a PCR-based assay developed by the US Centers for Disease Control and Prevention to detect Zika virus.

The Trioplex Real-time RT-PCR Assay tests patient samples for chikungunya, dengue, and Zika viruses in a single test. Symptoms of Zika, chikungunya, and dengue infection are similar and a PCR-based assay may be advantageous for early detection and because immunoassays reportedly tend to show cross-reactivity between these pathogens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.